Exercise is the Most Important Medicine for COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Exercise is the Most Important Medicine for COVID-19

Torres, Georgia PhD; Constantinou, Demitri MBChB, FACSM; Gradidge, Philippe PhD; Patel, Deepak MD; Patricios, Jon MBBCh, MMedSci Current Sports Medicine Reports 22(8):p 284-289, August 2023. | DOI: 10.1249/JSR.0000000000001092 Abstract COVID-19 infection and long COVID affect multiple organ systems, including the respiratory, cardiovascular, renal, digestive, neuroendocrine, musculoskeletal systems, and sensory organs. Exerkines, released during exercise, have a potent crosstalk effect […]

Risk of smell loss from covid has plummeted since 2020

Posted on | Posted on John Murphy | Leave a Comment on Risk of smell loss from covid has plummeted since 2020

New research shows steep drops in the rates of smell loss with recent omicron variants By Aara’L Yarber August 2023 When the pandemic began, losing your sense of smell was considered a key indicator of covid-19, and the condition affected about half of those who tested positive for the coronavirus. However, a new study reveals that the chance of smell loss […]

Can This Common Medication Help Reduce The Risk Of Long COVID?

Posted on | Posted on John Murphy | Leave a Comment on Can This Common Medication Help Reduce The Risk Of Long COVID?

A recent study suggests that the treatment may help some high-risk people following an infection. By Casey Clark Aug 29, 2023 It seems like every time you turn on the news or open your phone, new information about COVID-19 pops up. Most of this information is pertinent to the latest variant EG.5, also called “Eris,” but recently, other more […]

SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy

Posted on | Posted on John Murphy | Leave a Comment on SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy

Marcelo Merello, Kailash P Bhatia, Jose A Obeso Published: November 27, 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30442-7 Lancet Neurology VOLUME 20, ISSUE 2, P94-95, FEBRUARY 2021 During the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS […]

Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China

Posted on | Posted on John Murphy | Leave a Comment on Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China

Front. Aging Neurosci., 05 May 2023 Sec. Parkinson’s Disease and Aging-related Movement DisordersVolume 15 – 2023 | https://doi.org/10.3389/fnagi.2023.1138418 Li Wu1† Jun Shen1† Yuhan Jiang1 Xiaolei Shen1 Ping Wang1 Xin Nie2 Wenyan Kang3,4* Jianren Liu1* Wei Chen1* Background: Clinical manifestations of Parkinson’s disease (PD) after Corona Virus Disease 2019 (COVID-19) infection are poorly investigated. Objective: We aimed to explore the clinical features and outcomes of hospitalized PD […]

Early-stage trial for Parkinson’s disease therapy shows signs of promise

Posted on | Posted on John Murphy | Leave a Comment on Early-stage trial for Parkinson’s disease therapy shows signs of promise

Small trial of Bemdaneprocel, which aims to replace dopamine-producing neurons, raises hope for treatment. Hannah Devlin Science correspondent 28 Aug 2023 03.00 EDT Scientists have reported early success in a trial of an experimental cell therapy for Parkinson’s disease, raising hope for patients. Bemdaneprocel therapy is at an early stage, and the year-long trial involved just […]

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* Front. Neurol., 18 May 2023 Sec. Movement Disorders Volume 14 – 2023 | https://doi.org/10.3389/fneur.2023.1172416 SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality. Parkinson’s disease (PD) is the […]

Covid to blame for just 1% of weekly deaths from all causes across the US, CDC data shows

Posted on | Posted on John Murphy | Leave a Comment on Covid to blame for just 1% of weekly deaths from all causes across the US, CDC data shows

By ALEXA LARDIERI U.S. DEPUTY HEALTH EDITOR DAILYMAIL.COM 29 August 2023 Covid was to blame for just 1 percent of weekly deaths from all causes across the US in the most recent week, CDC data shows. The Centers for Disease Control and Prevention (CDC) Covid dashboard shows 324 Covid deaths were registered in the week ending […]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

npj Parkinson’s Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus on Parkinson’s disease. Major points include that neuropathology studies have not answered the central issue of whether the virus enters central […]

Large study provides scientists with deeper insight into long COVID symptoms

Posted on | Posted on John Murphy | Leave a Comment on Large study provides scientists with deeper insight into long COVID symptoms

May 25, 2023, 11:00 AM EDT NHLBI NEWS News Release NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the […]